allantoin; 97-59-6; 5-Ureidohydantoin; Glyoxyldiureide; 1-(2,5-dioxoimidazolidin-4-yl)urea; Glyoxyldiureid; Allantol; Cordianine; Sebical; Alantan; AVC/Dienestrolcream; Urea, (2,5-dioxo-4-imidazolidinyl)-; Hydantoin, 5-ureido-; (2,5-Dioxo-4-imidazolidinyl)urea; Cutemol emollient; Uniderm A; Glyoxylic diureide; Glyoxylic(acid) diureide; NSC 7606; Psoralon; Septalan; Caswell No. 024; 5-Ureido-2,4-imidazolidindion; (2,5-dioxoimidazolidin-4-yl)urea; N-(2,5-Dioxo-4-imidazolidinyl)urea; CCRIS 1958; 2,5-Dioxo-4-imidazolidinyl-urea; Fancol TOIN; 5-Ureidohydrantoin; MFCD00005260; EPA Pesticide Chemical Code 085701; C4H6N4O3; 4-ureido-2,5-Imidazolidinedione; AI3-15281; NSC7606; Allantoin (JAN/USP); N-(2,5-dioxoimidazolidin-4-yl)urea; 97-59-6 (racemic); urea, N-(2,5-dioxo-4-imidazolidinyl)-; MLS000737882; 5-Ureido-2,4-imidazolidindione; CHEBI:15676; Allantoin, 98%; 3844-67-5; [(4S)-2,5-dioxoimidazolidin-4-yl]urea; DSSTox_CID_43; Herpecin L; D00121; DSSTox_RID_75334; DSSTox_GSID_20043; Allantoin [USAN:BAN]; SMR000528073; amino-N-(2,5-dioxo(1,3-diazolidin-4-yl))amide; SR-01000766252; EINECS 202-592-8; BRN 0102364; Allantoi; DL-Allantoin; HSDB 7490; Allantoin [USAN:USP:BAN:JAN]; CAS-97-59-6; Prestwick_11; NCGC00016358-01; Allation,(S); 5-ureido-Hydantoin; Allantoin (8CI); (+/-)-Allantoin; 1219402-51-3; Spectrum_001078; ACMC-209twn; Prestwick0_000002; Prestwick1_000002; Prestwick2_000002; Prestwick3_000002; Spectrum2_000219; Spectrum3_000876; Spectrum4_000716; Spectrum5_001526; bmse000437; EC 202-592-8; SCHEMBL3208; Oprea1_621175; BSPBio_000003; BSPBio_002551; KBioGR_001271; KBioSS_001558; 5-25-15-00338 (Beilstein Handbook Reference); MLS002473300; Allantoin, analytical standard; DivK1c_000281; SPECTRUM1500801; Allantoin-[13C2,15N4]; SPBio_000237; SPBio_001924; BPBio1_000005; CHEMBL593429; DTXSID3020043; 5-Ureidohydantoin;Glyoxyldiureide; HMS500O03; KBio1_000281; KBio2_001558; KBio2_004126; KBio2_006694; KBio3_002051; Allantoin, >=98.0% (N); NINDS_000281; Urea,5-dioxo-4-imidazolidinyl)-; HMS1568A05; HMS1921I10; HMS2092K16; HMS2095A05; HMS2268N08; HMS3712A05; HMS3885M08; Pharmakon1600-01500801; AMY13912; BCP31832; component of Skin-balm (Salt/Mix); HY-N0543; NSC-7606; 2,5-Imidazolidinedione, 4-ureido-; Tox21_110395; Tox21_202087; Tox21_302912; ANW-43029; BBL027508; CCG-39781; NSC757792; s3856; SBB003997; STL373778; AKOS000120642; AKOS016038547; Tox21_110395_1; CS-7741; DB11100; MCULE-1008326286; NSC-757792; SDCCGMLS-0066595.P001; 1-(2,5-Dioxoimidazolidin-4-yl);urea; IDI1_000281; Allantoin, p.a., 98.5-101.0%; N-(2,5-Dioxo-4-imidazolidinyl)urea #; NCGC00094854-01; NCGC00094854-02; NCGC00094854-03; NCGC00094854-04; NCGC00094854-05; NCGC00094854-07; NCGC00256403-01; NCGC00259636-01; (RS)-(2,5-dioxoimidazolidin-4-yl)urea; AC-11040; AK-77679; AS-13865; H736; NCI60_041675; N-(2,5-Dioxo-4(1h)-imidazolidinyl)urea; SBI-0051759.P002; A0211; AB00052307; FT-0604592; ST50308144; C01551; J10470; M-5668; Urea, (2,5-dioxo-4-imidazolidinyl)- (9CI); AB00052307_11; Q409804; J-522839; SR-01000766252-2; SR-01000766252-3; SR-01000766252-4; W-100104; Allantoin, European Pharmacopoeia (EP) Reference Standard; A999F0D6-0285-41D9-A6BA-B705987B663C; Allantoin, United States Pharmacopeia (USP) Reference Standard; Allantoin, Pharmaceutical Secondary Standard; Certified Reference Material; 5-Ureidohydantoin; Glyoxyldiureide; Glyoxylic diureide; Cordianine; Glyoxyldiureid; (2,5-Dioxo-4-imidazolidinyl)urea